Launch of Azela tablet for asthma and allergic diseases

 

 

 

Title: Launch of Azela tablet for asthma and allergic diseases

KyungDong Pharm launched Azela tablets, which have a wide range of indications for asthma, allergic rhinitis, and allergic skin diseases, in November 2001.

Asthma and allergic diseases frequently metastasize or coexist with each other. In this case, Azela acts on both asthma and allergic diseases, so it is an advanced product that not only has multiple effects but can also block the transition process from allergic diseases to asthma.
In addition, Azela is a highly safe product that does not have sedative effects such as drowsiness and does not have concerns about cardiotoxicity that occurs with other antihistamines. It also has no drug interactions, so it can be administered in combination with any drug, making it more convenient and versatile.

 

 

Azela Jeong

● Ingredients/Content
1 tablet of this medicine
Azelastine hydrochloride 1mg

●Efficacy/Effectiveness
Bronchial asthma, allergic rhinitis, urticaria, eczema/dermatitis, atopic dermatitis, skin pruritus, itching

●Usage/Dosage
1 tablet at a time (2 tablets at a time in case of bronchial asthma), administered orally twice a day after breakfast and before bedtime.

●Packing unit
100 tablets